Rahul Banerjee/X
Dec 5, 2024, 07:37
Rahul Banerjee: Multiple Myeloma – Hematologic Toxicities and Advances in Quad Therapies
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center at the University of Washington, shared a post on X:
“ASH24. Looking for mind-blowing facts on Saturday afternoon?
- Dara improves OS in ASCT-eligible myeloma.
- 42% of MMsm patients have CHIP.
- SC boosts fix ICAHT .
- Fix Immunoparesis with flu.x3 or IVIG.
- sMRD 10^-5 = sMRD 10^-6.
How much am I oversimplifying? Come find out!”
More posts featuring Rahul Banerjee.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 15:06
Feb 21, 2025, 14:27
Feb 21, 2025, 14:13
Feb 21, 2025, 13:29